The impact of HB149 is significant as it mandates that the Department of Health along with the Children, Youth and Families Department cannot operate or contract with facilities that impose restrictions on MAT for minors. By the end of fiscal year 2025, any facility that does not comply with these regulations will be ineligible for Medicaid reimbursement for services rendered to minors. This initiative aims to remove barriers to accessing critical treatment for youth with substance use disorders, potentially improving health outcomes and reducing long-term addiction issues.
Summary
House Bill 149 introduced in New Mexico seeks to address the availability and usage of medication-assisted treatment (MAT) for minors undergoing substance abuse treatment. Specifically, the bill prevents any restriction on the use of MAT in inpatient and outpatient programs that are operated or funded by the state. The goal is to ensure that all minors have access to evidence-based treatment options for substance use disorders, reflecting a growing understanding of the importance of comprehensive care in addiction treatment for younger populations.
Contention
The bill's introduction may spark discussions and debates regarding the efficacy and appropriateness of medication-assisted treatments for minors, as some may argue about the implications of prescribing medications to young individuals. Concerns might arise regarding the balance between providing necessary treatment and ensuring that minors are not being subjected to pharmacological therapies prematurely. Furthermore, there could be discussions surrounding the funding allocations to ensure that the 'evidence-based addiction treatment for minors fund' is adequately supported, thereby enabling the establishment and operation of these mandated programs.
A bill for an act relating to services and support for youth, including treatment, physical assessments, and behavioral health evaluations; exemptions from children's residential facility certification; the director of juvenile court services and chief juvenile court officers; and suspension of Hawki eligibility for public institution inmates.(See HF 833, HF 984.)
A bill for an act relating to services and support for youth, including treatment, physical assessments, and behavioral health evaluations; exemptions from children's residential facility certification; the director of juvenile court services and chief juvenile court officers; and suspension of Hawki eligibility for public institution inmates.(See SF 474.)
Residential Substance Use Disorder Treatment Act of 2023 This bill revises and reauthorizes through FY2027 grants for residential substance use disorder treatment programs at state and local correctional and detention facilities. Among the revisions, the bill replaces statutory references to substance abuse with substance use disorder, specifies that the term residential substance use disorder treatment program includes a medication-assisted treatment program, requires the chief medical officer or other staff overseeing a program to complete training on the science of addiction and the latest research and clinical guidance on treating substance use disorders in criminal justice settings, and allows people who are awaiting trial or in pretrial detention to participate in the programs.
Requiring licensure of outpatient substance use disorder treatment facilities and relative to complaint investigation of treatment facilities by the department of health and human services office of the ombudsman and making an appropriation therefor.
Establishing the Nonnarcotic Medication Substance Use Disorder Treatment Program; in organization and jurisdiction of courts of common pleas, providing for court assessments for substance use disorder treatment; in other criminal provisions, further providing for supervisory relationship to offenders; and, in Pennsylvania Board of Probation and Parole, further providing for supervisory relationship to offenders.